3SBio Inc (83B) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.037x

Based on the latest financial reports, 3SBio Inc (83B) has a cash flow conversion efficiency ratio of 0.037x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€592.24 Million ≈ $692.39 Million USD) by net assets (€15.96 Billion ≈ $18.66 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of 3SBio Inc to measure how much of total assets are equity-financed.

3SBio Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how 3SBio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 3SBio Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

3SBio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of 3SBio Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ultrapar Participacoes SA ADR NYSE:UGP	0.141x
Black Hills Corporation NYSE:BKH	0.044x
ESAB Corp NYSE:ESAB	0.021x
Casella Waste Systems Inc NASDAQ:CWST	0.040x
Garrett Motion Inc NASDAQ:GTX	-0.125x
Shenzhen Everwin Precision Tech SHE:300115	-0.016x
Coca-Cola Icecek AS IS:CCOLA	0.047x
Longfor Group Holdings Limited F:RLF	0.027x

Annual Cash Flow Conversion Efficiency for 3SBio Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of 3SBio Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of 3SBio Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€30.44 Billion ≈ $35.58 Billion	€9.67 Billion ≈ $11.30 Billion	0.318x	+78.98%
2024-12-31	€18.04 Billion ≈ $21.09 Billion	€3.20 Billion ≈ $3.74 Billion	0.177x	+40.72%
2023-12-31	€16.51 Billion ≈ $19.31 Billion	€2.08 Billion ≈ $2.44 Billion	0.126x	-10.91%
2022-12-31	€15.40 Billion ≈ $18.00 Billion	€2.18 Billion ≈ $2.55 Billion	0.142x	+31.48%
2021-12-31	€14.66 Billion ≈ $17.14 Billion	€1.58 Billion ≈ $1.85 Billion	0.108x	+4.86%
2020-12-31	€13.09 Billion ≈ $15.31 Billion	€1.34 Billion ≈ $1.57 Billion	0.103x	-43.64%
2019-12-31	€10.36 Billion ≈ $12.11 Billion	€1.89 Billion ≈ $2.21 Billion	0.182x	+41.09%
2018-12-31	€8.91 Billion ≈ $10.41 Billion	€1.15 Billion ≈ $1.34 Billion	0.129x	-8.27%
2017-12-31	€7.63 Billion ≈ $8.92 Billion	€1.07 Billion ≈ $1.26 Billion	0.141x	-5.15%
2016-12-31	€6.77 Billion ≈ $7.91 Billion	€1.00 Billion ≈ $1.17 Billion	0.148x	--

About 3SBio Inc

F:83B Germany Biotechnology

Market Cap

$5.59 Billion

€4.78 Billion EUR

Market Cap Rank

#3337 Global

#627 in Germany

Share Price

€1.91

Change (1 day)

+3.33%

52-Week Range

€1.63 - €3.88

All Time High

€3.88